| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 39 | 0.0008 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 36 | 0.0003 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Alkaloid [EPC] | 1 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |